Skip to main content
Signal8
Sorg Elaine K. profile photo

Elaine K. Sorg

CIK: 0001832571

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Artiva Biotherapeutics, Inc. logo
ARTV

Artiva Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 10, 2026
    Award(A)

    Director Stock Option (Right to Buy)

    Direct
    16.3K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Sep 8, 2026
    Award(A)

    Director Stock Option (Right to Buy)

    Direct
    13.8K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Feb 18, 2026
    Award(A)

    Director Stock Option (Right to Buy)

    Direct
    27.5K shares-

1-3 of 3

About Sorg Elaine K.

Sorg Elaine K. (SEC CIK 0001832571) files insider reports with the SEC as Director of Artiva Biotherapeutics, Inc. (ARTV).

Signal8 holds 4 ownership filings by Sorg Elaine K. (1 Form 3, 3 Form 4), filed between Feb 19, 2026 and Sep 14, 2026. Those filings report 3 transactions, from Feb 18, 2026 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sorg Elaine K.'s filings is in SAN DIEGO, CA.

Recent filings by Sorg Elaine K.

  • Sep 10, 2026: Grant or award of ARTV derivative securities (Form 4, code A).
  • Sep 8, 2026: Grant or award of ARTV derivative securities (Form 4, code A).
  • Feb 18, 2026: Grant or award of ARTV derivative securities (Form 4, code A).

Other insiders filing for Artiva Biotherapeutics, Inc. (ARTV)

How to read Form 4 transaction codes